EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Therapeutic Targeting of RNA Splicing in Cancer

Elizabeth A Bonner, Stanley C Lee

Genes · 29.06.2023 · 14 (7) · 1378

DOI: 10.3390/genes14071378 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Genes, online erschienen am 29.06.2023. Verfasst von Elizabeth A Bonner und 1 weiteren Autor:innen. Beteiligte Einrichtung: Molecular and Cellular Biology Graduate Program, University of Washington, Seattle, WA 98195, USA. Hauptthemen laut MEDLINE: RNA Splicing, Neoplasms. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 130 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RNA splicing is a key regulatory step in the proper control of gene expression. It is a highly dynamic process orchestrated by the spliceosome, a macro-molecular machinery that consists of protein and RNA components. The dysregulation of RNA splicing has been observed in many human pathologies ranging from neurodegenerative diseases to cancer. The recent identification of recurrent mutations in the core components of the spliceosome in hematologic malignancies has advanced our knowledge of how splicing alterations contribute to disease pathogenesis. This review article will discuss our current understanding of how aberrant RNA splicing regulation drives tumor initiation and progression. We will also review current therapeutic modalities and highlight emerging technologies designed to target RNA splicing for cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA SplicingNeoplasmsHumansSpliceosomesRNA Splicing FactorsRNA

Stichwörter der Autor:innen

alternative splicinganti-sense oligonucleotidesimmuno-oncology therapiesspliceosome inhibitorssplicing factor mutations

Substanzen

RNA Splicing FactorsRNA

Autor:innen und Institutionen

  • Molecular and Cellular Biology Graduate Program, University of Washington, Seattle, WA 98195, USA.
  • Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
  • Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA 98195, USA.

Förderung

  • NCI NIH HHS

Zitieren

APA

Bonner, E. A., & Lee, S. C. (2023). Therapeutic Targeting of RNA Splicing in Cancer. Genes, 14(7), 1378. https://doi.org/10.3390/genes14071378

Vancouver

Bonner EA, Lee SC. Therapeutic Targeting of RNA Splicing in Cancer. Genes. 2023;14(7):1378. doi:10.3390/genes14071378

BibTeX
@article{Bonner2023,
  author = {Bonner, Elizabeth A and Lee, Stanley C},
  title = {Therapeutic Targeting of RNA Splicing in Cancer},
  journal = {Genes},
  year = {2023},
  volume = {14},
  number = {7},
  pages = {1378},
  doi = {10.3390/genes14071378}
}
Kostenlos starten →